Bicycle Therapeutics PLC (BCYC)
21.79
-0.79
(-3.50%)
USD |
NASDAQ |
Nov 15, 16:00
21.76
-0.02
(-0.11%)
After-Hours: 20:00
Bicycle Therapeutics Revenue (Annual): 26.98M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 26.98M |
December 31, 2022 | 14.46M |
December 31, 2021 | 11.70M |
December 31, 2020 | 10.39M |
Date | Value |
---|---|
December 31, 2019 | 13.80M |
December 31, 2018 | 7.136M |
December 31, 2017 | 2.06M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
10.39M
Minimum
2020
26.98M
Maximum
2023
15.47M
Average
13.80M
Median
2019
Revenue (Annual) Benchmarks
Adaptimmune Therapeutics PLC | 60.28M |
NuCana PLC | -- |
TC BioPharm (Holdings) PLC | -- |
Autolus Therapeutics PLC | 1.698M |
Biodexa Pharmaceuticals PLC | 0.4741M |